mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
DC

Dishman Carbogen Amcis Limited

NSE:DCALBSE:DCAL
HealthcarePharmaceuticals & Biotechnology
₹150.4
-4.52%1 Oct close
Mkt cap
₹2,357 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
AnnualQuarterly
ConsolidatedStandalone

Standalone figures · ₹ crore

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
7474474549581208303403327400232
COGS1291551551632001089917111613139
Gross profit-122319319387381100203231211269192
-260153153193207157169223205197187
138166166194174-573487725
OPM %—35.1%35.1%35.3%29.9%-27.6%11.3%1.9%2.1%18%2.3%
Depreciation136134134136141143140961026563
Interest135354747343758687087
066667270665950603385
Profit before tax162628255-169-84-96-103-31-59
Tax02525261764-53-37-27-21-21
Tax %10.9%40.4%40.4%31.5%30.5%38%-62.6%-38.8%-25.8%-68%-35.2%
137375639-233-32-59-76-10-38
PAT margin %13.1%7.8%7.8%10.2%6.6%-111.9%-10.4%-14.6%-23.3%-2.5%-16.6%
EPS (₹)35.72.32.33.52.5-14.9-2-3.8-4.9-0.6-2.5
EPS adjusted (₹)35.62.32.33.52.5-14.9-2-3.8-4.9-0.6-2.5
0%0%0%5.8%0%——————
Annual report—Annual report for Mar 2017Annual report for Mar 2018Annual report for Mar 2019Annual report for Mar 2020Annual report for Mar 2021Annual report for Mar 2022Annual report for Mar 2023Annual report for Mar 2024Annual report for Mar 2025—

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital032323231313131313131
Reserves-14,7714,7594,8604,7644,6434,2004,0834,0213,9993,851
10401536284479526527590524679631
3333479640460351456477500413613
Total equity & liabilities125,5375,8075,8165,7355,5525,2145,1815,0775,1225,126
01,9271,8531,7151,6181,4941,3561,3751,4001,3901,365
CWIP02916385795114142734123
Investments02,7612,9372,9072,9002,8823,0322,9132,8482,8412,844
128191,0011,1561,1591,081712751755851894
Total assets125,5375,8075,8165,7355,5525,2145,1815,0775,1225,126

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2022 · ₹ crore

SegmentRevenueResultAssetsLiabilities
CRAMS00—0
OTHERS00—0

CRAMS · revenue

₹ crore by fiscal year

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
327020120197-2227-53245646
0-19-175-24-7462-1734197-8022
-2-225142-85-124-71-461-13188-120
Net cash flow126-1210-2-109-11-1064-52
Free cash flow-98170-5569—-49188-176-12119
CFO / Operating profit %1.9%162.6%12.1%61.8%113.3%—665%-681.7%355.4%77.7%866.7%

Compounded sales growth

7 years
-12%
5 years
2%
3 years
-17%
1 year
-42%

Stock price CAGR

10 years
—
5 years
-6%
3 years
-4%
1 year
-49%

Return on equity

7 years
-1%
5 years
-1%
3 years
-1%
Last year
-1%